Download Files:
Telotristat etiprate
SKU
HY-13055-10 mg
Category Reference compound
Tags Metabolic Enzyme/Protease, Neurological Disease; Cancer, Tryptophan Hydroxylase
$77 – $418
Products Details
Product Description
– Telotristat etiprate (LX1606 Hippurate) is a novel, orally-delivered inhibitor of tryptophan hydroxylase that reduces serotonin production.
Web ID
– HY-13055
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C36H35ClF3N7O6
References
– [1]Tamas Oravecz, et al. LX1606 (aka LX1032), a Novel Inhibitor of Serotonin Synthesis, Alleviates Development of Inflammatory Bowel Disease in a Preclinical Model.|[2]Margolis, K.G., et al., Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut, 2013.
CAS Number
– 1137608-69-5
Molecular Weight
– 754.15
Compound Purity
– 99.90
SMILES
– O=C([C@H](CC1=CC=C(C=C1)C2=CC(O[C@H](C3=C(C=C(C=C3)Cl)N4C=CC(C)=N4)C(F)(F)F)=NC(N)=N2)N)OCC.O=C(C5=CC=CC=C5)NCC(O)=O
Clinical Information
– Launched
Research Area
– Neurological Disease; Cancer
Solubility
– DMSO : 200 mg/mL (ultrasonic)
Target
– Tryptophan Hydroxylase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.